Parenteral and oral pharmacotherapy in prevention of osteoporotic fractures in postmenopausal osteoporosis

被引：1
|
作者：
Pawlak-Bus, Katarzyna [1 ,2 ]
Leszczynski, Piotr [1 ,2 ]
机构：
[1] Wielospecjalisty Szpital J Strusia, Oddzial Reumatol & Osteoporozy, PL-61001 Poznan, Poland
[2] Uniwersytet Med Karola Marcinkowskiego, Klin Reumatol & Rehabil, Pracownia Chorob Metab Kosci & Tkanki Lacznej, Poznan, Poland
来源：
PRZEGLAD MENOPAUZALNY | 2013年 / 12卷 / 03期
关键词：
postmenopausal osteoporosis; fracture prevention; bisphosphonates; denosumab; strontium ranelate; raloxifene; teriparatide;
D O I：
10.5114/pm.2013.36598
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Currently available drugs for the management of postmenopausal osteoporosis can confuse clinicians in daily practice. The number of new oral and therapeutic agents with a different mechanism of action can make a clinical decision to start more complex treatment than previously. This may confirm that in order to know how, when and whom to treat in postmenopausal osteoporosis, specific recommendations based on medical scientific evidence are needed. This manuscript offers compact and easily available information about antiresorptive drugs which can be used by physicians in clinical practice.
引用
收藏
页码：271 / 277
页数：7
相关论文
共 50 条
  • [31] A 10-YEAR FOLLOW UP OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FOR OCCURRENCE OF OSTEOPOROTIC FRACTURES
    Sunarso, S.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 281 - 281
  • [32] The prevention of osteoporotic fractures
    Karlsson, MK
    Gerdhem, P
    Ahlborg, HG
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2005, 87B (10): : 1320 - 1327
  • [33] Efficacy and safety of pharmacologic therapies for prevention of osteoporotic vertebral fractures in postmenopausal women
    Wei, Fei-Long
    Gao, Quan-You
    Zhu, Kai-Long
    Heng, Wei
    Du, Ming-Rui
    Yang, Fan
    Gao, Hao-Ran
    Li, Tian
    Qian, Ji-Xian
    Zhou, Cheng-Pei
    HELIYON, 2023, 9 (02)
  • [34] Implementation of and compliance with NICE guidelines in the secondary prevention of osteoporotic fractures in postmenopausal women
    Javid, K. S.
    Thien, A.
    Hill, R.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2008, 90 (03) : 213 - 215
  • [35] Outcomes of Treatment in Patients with Elderly Postmenopausal Osteoporosis: Comparision of Oral and Parenteral Bisphosphonates
    Aslan, Ahmet
    Gulcu, Anil
    Ozmeric, Ahmet
    TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, 2018, 24 (02): : 53 - 58
  • [36] Weekly dosing of oral ibandronate is effective in the prevention of postmenopausal osteoporosis
    Felsenberg, D
    Christiansen, C
    Cerwinski, E
    Burdeska, A
    Jonkanski, I
    Meinert, R
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S16 - S17
  • [37] Raloxifene is an effective option for the prevention of vertebral fractures associated with postmenopausal osteoporosis
    不详
    Drugs & Therapy Perspectives, 2004, 20 (11) : 1 - 5
  • [38] PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
    DIRENZO, GC
    COATA, G
    COSMI, EV
    MELIS, GB
    VOLPE, A
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1993, 49 (1-2): : 56 - 56
  • [39] PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
    CHAOUAT, D
    SEMAINE DES HOPITAUX, 1991, 67 (37): : 1685 - 1691
  • [40] Postmenopausal Osteoporosis Prevention
    不详
    NURSE PRACTITIONER, 2006, 31 (04): : 70 - 70
12345